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Abstract Phytochemical investigation of the rhizomes of Paris polyphylla var. stenophylla led to the isolation of two new
highly oxygenated spirostanol saponins, named paristenosides A (1) and B (2), together with seven known compounds. Their
structures were established mainly on the base of NMR spectroscopic techniques and mass spectrometry, as well as chemical
methods. In addition, the cytotoxicity of the two new saponins was tested.
Graphical Abstract Two new highly oxygenated spirostanol saponins, paristenosides A (1) and B (2), were isolated from the
rhizomes of Paris polyphylla var. stenophylla. Their structures were established mainly based on NMR spectroscopic techniques
and mass spectrometry, as well as chemical methods.
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1 Introduction
The genus Paris (Liliaceae) comprises about 24 species,
which grows as perennial rhizomatous herbs in the Eur-
asian continent from temperate zone to the tropics [1].
Rhizoma Paridis (‘Chonglou’ in Chinese), the dried rhi-
zomes of P. polyphylla var. yunnanensis and P. polyphylla
var. chinensis, have been recorded in the Pharmacopoeia of
the People’s Republic of China as a traditional Chinese
medicine for the treatment of traumatic injuries, insect and
snake bites, and sore throat [2]. Plants of the genus Paris
are known as a rich source of steroidal saponins, which
have attracted great interests for their structural diversity
and various bioactivities such as anti-tumor [3, 4], hemo-
static [5], and antifungal [6] effects. In recent years, our
group focuses the research on the chemical constituents,
bioactivity, and sustainable utilization of resources of the
genus [7–11].
P. polyphylla var. stenophylla Franch. is one of the
variations of P. polyphylla and has been used as a herbal
medicine to treat skin furuncle and skin tinea, stop
bleeding, and move clean blood and bad blood out by
the Yi nationality of Liangshan in Sichuan Province [12].
Due to having certain resources, its rhizomes have been
as the main steam commodities of Rhizoma Paridis.
However, there are a few reports about the research of
its material basis [13]. In order to clarify its chemical
quality, we performed a phytochemical investigation of
the rhizomes of P. polyphylla var. stenophylla. As a
result, two new polyhydroxylated steroidal saponis,
named paristenosides A (1) and B (2), were isolated from
the title species. Meanwhile, seven known compounds
were obtained and identified as paris saponin H (3) [14],
Tg (4) [15], Pb (5) [16], Th (6) [17], Methyl-Th (7) [18],
parispseudoside A (8) [19] and b-ecdysone (9) [16]. In
the current paper, we report the isolation, structural
elucidation, and cytotoxicity of the two new compounds
(Fig. 1).
2 Results and Discussion
Paristenoside A (1) was isolated as a white amorphous
powder. Its molecular formula, C50H80O25, was assigned
by the positive-ion HR-ESI-MS (m/z 1103.4881
[M ? Na]?, calcd for 1103.4881) and 13C NMR data
(Tables 1, 2). The IR spectrum displayed absorption bands
ascribable to hydroxy (3426 cm-1) and olefinic bond
(1631 cm-1) functionalities. The 13C NMR spectrum
showed signals for a ketal carbon at dC 111.5, a trisubsti-
tuted olefin carbons at dC 139.4 (s) and 124.6 (d), and three
methyls at dC 17.0, 15.0, and 13.1, which were character-
istic of a D5,6-spirostanol skeleton as an aglycone [7]. Its
1H NMR spectrum showed two singlet signals for two
tertiary methyls at dH 1.38 and 1.13, one doublet signal for
a secondary methyl at dH 1.03 (d, J = 6.8 Hz), an olefinic
proton at dH 5.55 (br d, J = 5.5 Hz), as well as four
anomeric protons at dH 6.41 (br s), 5.24 (d, J = 7.8 Hz),
4.91 (d, J = 7.6 Hz), and 4.78 (d, J = 7.7 Hz), which
suggested the presence of four sugar units. In addition, one
methyl at dH 1.71 (d, J = 6.0 Hz) was the methyl of one
6-deoxyhexopyranose residue. Comparison of the 1H and
13C NMR spectra of 1 with those of padelaoside A [20]
revealed that 1 possessed the same polyhydroxylated
aglycone [(23S,24S,25S)-spirost-5-ene-1b,3b,21,23,24-
pentol] as that of padelaoside A, which could be further
verified by detailed 2D NMR data analysis (Figs. 2, 3).
Furthermore, the result of acid hydrolysis and GC analysis
of 1 with its corresponding trimethylsilated L-cysteine
adducts afforded D-glucose, D-galactose, D-xylose, and
L-rhamnose. The large coupling constants (3J1,2[ 7 Hz)
were consistent with b-configuration for the glucose,
galactose, and xylose, while the a-configuration for the
rhamnose was deduced by comparing its 13C NMR spec-
troscopic data for C-300 (dC 72.4) and C-500 (dC 69.5) with
those reported in the literature [21]. The sequence and
binding sites of the sugar units were determined by fol-
lowing HMBC correlations: dH 6.41 (H-100 of Rha) with dC
Fig. 1 Chemical structures of paristenosides A (1) and B (2)
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76.3 (C-20 of Glc), dH 4.91 (H-1000 of Xyl) with dC 88.3 (C-
30 of Glc), dH 4.78 (H-10 of Glc) with dC 83.9 (C-1 of the
aglycone), and dH 5.24 (H-10000 of Gal) with dC 81.8 (C-24
of the aglycone). Assignment of all proton and carbon
resonances was achieved by interpretation of 1H-1H COSY,
HSQC, and HMBC spectra. Based on the above informa-




Paristenoside B (2) was obtained as a white amorphous
powder with a molecular formula of C56H88O30, which was
deduced from the positive HR-ESI-MS (m/z 1258.5689
[M ? NH4]
?, calcd for 1258.5699) and 13C NMR data
(Tables 1, 2). The 1H and 13C NMR data suggested that
compound 2 was also a highly oxygenated spirostanol
Table 1 1H and 13C NMR data for the aglycone portions of paristenosides A (1) and B (2) (in C5D5N, 600 MHz)
No. Paristenoside A Paristenoside B
dC dH (mult., J in Hz)
a dC dH (mult., J in Hz)
a
1 83.9 (CH) 3.85 (dd, 12.0, 3.8) 84.6 (CH) 3.77 (dd, 11.9, 3.9)
2a 37.7 (CH2) 2.65 38.0 (CH2) 2.63
2b 2.38 (q, 11.9) 2.39 (q, 12.0)
3 67.9 (CH) 3.74 (m) 67.9 (CH) 3.73 (m)
4a 43.6 (CH2) 2.66 (br t, 12.2) 43.7 (CH2) 2.65 (t, 12.6)
4b 2.54 (dd, 11.6, 3.7) 2.52 (dd, 12.0, 3.5)
5 139.4 (C) 139.3 (C)
6 124.6 (CH) 5.55 (br d, 5.5) 124.7 (CH) 5.52 (br d, 5.3)
7a 31.7 (CH2) 1.67 (m) 31.7 (CH2) 1.72 (m)
7b 1.40 (m) 1.43 (m)
8 33.0 (CH) 1.48 (m) 32.9 (CH) 1.45 (m)
9 50.0 (CH) 1.61 (m) 50.2 (CH) 1.59 (m)
10 42.6 (C) 42.6 (C)
11a 24.0 (CH2) 2.82 (m) 23.9 (CH2) 2.77 (m)
11b 1.61 (m) 1.47 (m)
12a 40.2 (CH2) 1.92 (m) 39.9 (CH2) 1.88 (br d, 9.5)
12b 1.48 1.46
13 41.0 (C) 40.9 (C)
14 56.9 (CH) 1.15 (m) 56.9 (CH) 1.14 (m)
15a 32.4 (CH2) 1.80 (m) 32.2 (CH2) 1.80 (m)
15b 1.47 1.43
16 83.1 (CH) 4.58 83.3 (CH) 4.53
17 58.1 (CH) 2.00 (t, 7.2) 58.1 (CH) 1.94 (t, 7.5)
18 17.0 (CH3) 1.13 (s) 16.8 (CH3) 1.03 (s)
19 15.0 (CH3) 1.38 (s) 14.9 (CH3) 1.32 (s)
20 46.0 (CH) 3.34 (br t, 5.6) 43.5 (CH) 3.42 (q, 6.7)
21a 62.5 (CH2) 4.20 (m) 69.8 (CH2) 4.43 (m)
21b 4.04 (m) 3.94 (m)
22 111.5 (C) 111.3 (C)
23 71.1 (CH) 4.10 (m) 71.1 (CH) 4.34 (d, 2.6)
24 81.8 (CH) 4.17 (m) 82.0 (CH) 4.68 (d, 2.6)
25 35.1 (CH) 1.93 (m) 143.4 (C)
26a 61.4 (CH2) 3.98 (m) 61.4 (CH2) 4.84 (d, 12.2)
26b 3.35 (m) 3.98 (d, 12.2)
27a 13.1 (CH3) 1.03 (d, 6.8) 113.8 (CH2) 5.04 (s)
27b 4.96 (s)
a Overlapped signals are reported without designating multiplicity
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glycoside. A comparison of the NMR spectra of 2 with
those of parisyunnanoside I [22] disclosed that they both
had the same aglycone and sugar chain linkages at C-1 and
C-21, except for the replacement of the fucose by a
galactose at C-24 in the latter. This was further supported
by the HMBC correlation between dH 5.82 (H-100000 of Gal)
with dC 82.0 (C-24 of the aglycone). The other parts of 2
were identical to those of parisyunnanoside I as confirmed
by detailed analysis of its 2D NMR experiments. There-
fore, the structure of paristenoside B (2) was established as
21-O-b-D-galactopyranosyl-24-O-b-D-galactopyranosyl-(23S,
24S)-spirost-5,25(27)-diene-1b,3b,21,23,24-pentol-1-O-a-L-rh
amnopyranosyl-(1 ? 2)-[b-D-xylopyranosyl-(1 ? 3)]-b-D-gl
ucopyranoside.
The phytochemical investigation of the rhizomes of P.
polyphylla var. stenophylla led to the identification of eight
steroidal saponins and one ecdysone, including two new
highly oxygenated spirostanol glycosides. Compounds 1 and
2 are a further addition to the diverse and complex steroidal
saponins. Our results and the literature [13] suggested that P.
polyphylla var. stenophylla contained the same bioactive
components as those in the legally original plants of Rhi-
zoma Paridis. However, whether the rhizomes of P. poly-
phylla var. stenophylla can be used as the original plant of
Rhizoma Paridis are still valuable for us to further research.
Considering cytotoxicity of steroidal glycosides, paristeno-
sides A (1) and B (2) were evaluated for their cytotoxicity
against two human cancer cell lines (HEK293 and HepG2)
Table 2 1H and 13C NMR data for the sugar moieties of paristenosides A (1) and B (2) (in C5D5N, 600 MHz)
No. Paristenoside A No. Paristenoside B
dC dH (mult., J in Hz)
a dC dH (mult., J in Hz)
a
1-Glc-10 99.7 (CH) 4.78 (d, 7.7) 1-Glc-10 100.2 (CH) 4.73 (d, 7.6)
20 76.3 (CH) 4.13 (m) 20 76.2 (CH) 4.06
30 88.3 (CH) 4.03 (m) 30 88.2 (CH) 4.01 (t, 9.2)
40 70.1 (CH) 3.73 (m) 40 69.8 (CH) 3.83 (t, 9.2)
50 77.7 (CH) 3.77 (m) 50 77.6 (CH) 3.74 (m)
60a 63.1 (CH2) 4.45 (m) 60a 63.1 (CH2) 4.45 (m)
60b 4.14 (m) 60b 4.22 (m)
20-Rha-100 101.6 (CH) 6.41 (br s) 20-Rha-100 101.6 (CH) 6.34 (br s)
200 72.4 (CH) 4.75 (m) 200 72.4 (CH) 4.75
300 72.4 (CH) 4.57 (m) 300 72.3 (CH) 4.55 (dd, 9.5, 3.3)
400 74.1 (CH) 4.29 (m) 400 74.0 (CH) 4.28 (t, 9.4)
500 69.5 (CH) 4.81 (dq, 9.2, 6.3) 500 69.4 (CH) 4.78 (dq, 9.2, 6.2)
600 19.2 (CH3) 1.71 (d, 6.0) 600 19.1 (CH3) 1.70 (d, 6.1)
30-Xyl-100 0 105.1 (CH) 4.91 (d, 7.6) 30-Xyl-100 0 105.1 (CH) 4.90 (d, 7.7)
200 0 74.6 (CH) 3.95 (t, 8.1) 200 0 74.6 (CH) 3.92 (t, 8.2)
300 0 78.3 (CH) 4.06 (t, 8.9) 300 0 78.3 (CH) 4.05
400 0 70.5 (CH) 4.10 (m) 400 0 70.5 (CH) 4.08 (m)
500 0a 67.1 (CH2) 4.23 (dd, 11.3, 5.0) 500 0a 67.1 (CH2) 4.23 (m)
500 0b 3.66 (t, 10.6) 500 0b 3.66 (t, 10.8)
24-Gal-100 00 106.3 (CH) 5.24 (d, 7.8) 21-Gal-100 00 105.1 (CH) 4.85 (d, 7.5)
200 00 72.4 (CH) 4.56 200 00 72.3 (CH) 4.44
300 00 75.3 (CH) 4.14 (m) 300 00 75.3 (CH) 4.12 (dd, 9.4, 3.2)
400 00 70.0 (CH) 4.53 (m) 400 00 70.1 (CH) 4.52
500 00 76.9 (CH) 4.06 (br t, 8.8) 500 00 76.9 (CH) 4.06
600 00a 62.0 (CH2) 4.47 (m) 600 00 62.2 (CH2) 4.38 (2H, br d, 5.9)
600 00b 4.37 (m) 24-Gal-100 00 0 103.9 (CH) 5.82 (d, 8.2)
200 00 0 70.7 (CH) 4.64 (dd, 8.1, 2.9)
300 00 0 75.2 (CH) 4.68 (m)
400 00 0 71.1 (CH) 4.59 (br d, 3.2)
500 00 0 76.9 (CH) 4.06
600 00 0 62.3 (CH2) 4.31 (2H, dd, 11.0, 5.7)
a Overlapped signals are reported without designating multiplicity
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by using MTT method. Unfortunately, none of them showed
significant activity at the concentration of 20 lM.
3 Experimental Section
3.1 General Experimental Procedures
Optical rotations were recorded on a JASCO P-1020 digital
polarimeter. IR spectra were obtained on Bruker Tensor-27
infrared spectrophotometer with KBr pellets. ESI-MS
spectra were recorded on a Bruker HCT/Esquire spectrom-
eter. HR-ESI-MS were obtained on an Agilent 6200 Q-TOF
MS system. 1D and 2D NMR spectra were obtained on a
Bruker Avance III 600 MHz spectrometer in C5D5N;
chemical shifts are given in d (ppm), and coupling constants
are reported in Hz. Column chromatography (CC) was per-
formed on silica gel (200–300 mesh, Qingdao Puke Chem-
ical Co. Ltd., China) and Rp-18 gel (40–63 lm, Merck,
Darmstadt, Germany). GC analysis was performed on a
HP5890 gas chromatograph equipped with an H2 flame
ionization detector. Semi-preparative HPLC was run on
Agilent 1100 liquid chromatograph equipped with a Zorbax
SB-C18 column (5 lm, 25 cm 9 9.4 mm) and a diode array
detector (DAD). TLC was performed on HSGF254 (0.2 mm,
Qingdao Puke Chemical Co. Ltd., China). Fractions were
monitored by TLC and spots were visualized by heating
silica gel plates sprayed with 10 % H2SO4 in EtOH.
3.2 Plant Material
The rhizomes of P. polyphylla var. stenophylla were col-
lected in Octobor 2014 from Zhaoyang District, Zhaotong,
Yunnan province, China. The plant material was authenti-
cated by Dr. Yun-Heng Ji, Kunming Institute of Botany,
Chinese Academy of Sciences. A voucher specimen (No.
HY0023) was deposited at the State Key Laboratory of
Phytochemistry and Plant Resources in West China, Kun-
ming Institute of Botany, Chinese Academy of Sciences.
3.3 Extraction and Isolation
The air-dried and powdered rhizomes of P. polyphylla var.
stenophylla (370 g) were extracted three times with 75 %
EtOH under reflux and then the solvent was evaporated under
reduced pressure to afford a crude extract (10 g). The crude
extract was subjected to a silica gel column and eluted with a
CHCl3–MeOH (15:1 ? 1:2, v/v) gradient solvent system to
yield seven fractions (A–G). Fr. C (1.1 g) was chro-
matographed through a silica gel column (CHCl3–MeOH,
15:1 ? 1:1) and purified by semi-prep. HPLC (CH3CN-H2O,
40:60, v/v) to yield 3 (35 mg). Fr. E (1.5 g) was separated by
an Rp-18 column (CH3OH–H2O, 50:50 ? 70:30, v/v) to get
4 (9 mg) and 5 (30 mg). Fr. F (1.5 g) was separated by a silica
gel column, eluting with CHCl3–MeOH (10:1 ? 1:1) and
was further purified by semi-prep. HPLC with the mobile
phase of CH3CN–H2O (30:70, v/v) to obtain 1 (9 mg), 2
(5 mg), 6 (43 mg), 7 (50 mg), 8 (5 mg), and 9 (9 mg).
3.3.1 Paristenoside A (1)
White amorphous powder; a½ 23D -76.8 (c = 0.05, MeOH);
IR (KBr) vmax: 3426, 1631, 1383, 1051 cm
-1; 1H
Fig. 2 1H-1H COSY and Key HMBC correlations of paristenoside A
(1)
Fig. 3 Key ROESY correlations for the aglycone moiety of paristenoside A (1)
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(600 MHz, C5D5N) and
13C NMR (150 MHz, C5D5N)
data, see Tables 1 and 2; ESIMS m/z 1103 [M ? Na]?;
HRESIMS m/z 1103.4881 [M ? Na]? (cacld for
C50H80O25Na, 1103.4881).
3.3.2 Paristenoside B (2)
White amorphous powder; a½ 23D -55.8 (c = 0.09, MeOH);
IR (KBr) vmax: 3424, 1635, 1382, 1045 cm
-1; 1H
(600 MHz, C5D5N) and
13C NMR (150 MHz, C5D5N)
data, see Tables 1 and 2; ESIMS m/z 1263 [M ? Na]?;
HRESIMS m/z 1258.5689 [M ? NH4]
? (cacld for
C56H92O30N, 1258.5699).
3.4 Sugar Analysis of 1 and 2
Compounds 1 and 2 (each 2 mg) were refluxed with 2 M
HCl (1,4-dioxane/H2O 1:1, 2 mL) on water bath for 2 h.
The mixture was concentrated in a vacuum, and the residue
was suspended in H2O and then extracted with CHCl3
(5 mL 9 3). The aqueous layer was neutralized with
MeOH and then dried to give a mixture of sugars. Each
mixture was dissolved in anhydrous pyridine (1 mL) and
reacted with L-cysteine methyl ester hydrochloride
(1.5 mg) stirred at 60 C for 1.5 h. The trimethylsilylimi-
dazole (1.0 mL) was subsequently added to the reaction
mixtures, and they were kept at 60 C for 30 min. The
mixture (4 lL) was finally analyzed by an HP 5890 gas
chromatograph with a 30QC2/AC-5 quartz capillary col-
umn (30 mm 9 0.32 mm 9 0.25 lm), respectively, under
the following conditions: H2 flame ionization detector;
carrier gas: N2 (1 mL/min); column temperature program:
180–280 C with the rate of 3 C/min; injector tempera-
ture: 250 C; split ratio 1:50. Peaks of the hydrolysate were
detected by comparison with retention times of authentic
samples of D-glucose, D-galactose, D-xylose, and L-rhamnose
after the aforementioned treatment in pyridine. The absolute
configurations of the sugar moieties were identified as D-
glucose (tR = 19.0 min), D-galactose (tR = 23.0 min), D-
xylose (tR = 18.3 min), and L-rhamnose (tR = 15.4 min),
respectively.
3.5 Cytotoxic Assay
Cytotoxic evaluations were performed for two human cancer
cell lines (HEK293 and HepG2) using the MTT method
described in the literature elsewhere [10]. (-)-OddC was
used as the positive control and showed IC50 values for the
two cancer cell lines with IC50 values of 0.30 and 0.17 lM,
respectively. The experiments were conducted for three
independent replicates, and IC50[ 20 lM was considered
to be inactive.
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